Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Emerging therapeutic strategies in breast cancer (Oct 2026)
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Oral tolerance in the absence of naturally occurring Tregs
Daniel Mucida, Nino Kutchukhidze, Agustin Erazo, Momtchilo Russo, Juan J. Lafaille, Maria A. Curotto de Lafaille
Daniel Mucida, Nino Kutchukhidze, Agustin Erazo, Momtchilo Russo, Juan J. Lafaille, Maria A. Curotto de Lafaille
View: Text | PDF
Research Article Immunology

Oral tolerance in the absence of naturally occurring Tregs

  • Text
  • PDF
Abstract

Mucosal tolerance prevents pathological reactions against environmental and food antigens, and its failure results in exacerbated inflammation typical of allergies and asthma. One of the proposed mechanisms of oral tolerance is the induction of Tregs. Using a mouse model of hyper-IgE and asthma, we found that oral tolerance could be effectively induced in the absence of naturally occurring thymus-derived Tregs. Oral antigen administration prior to i.p. immunization prevented effector/memory Th2 cell development, germinal center formation, class switching to IgE, and lung inflammation. Oral exposure to antigen induced development of antigen-specific CD4+CD25+Foxp3+CD45RBlow cells that were anergic and displayed suppressive activity in vivo and in vitro. Oral tolerance to the Th2 allergic response was in large part dependent on TGF-β and independent of IL-10. Interestingly, Tregs were also induced by single i.p. immunization with antigen and adjuvant. However, unlike oral administration of antigen, which induced Tregs but not effector T cells, i.p. immunization led to the simultaneous induction of Tregs and effector Th2 cells displaying the same antigen specificity.

Authors

Daniel Mucida, Nino Kutchukhidze, Agustin Erazo, Momtchilo Russo, Juan J. Lafaille, Maria A. Curotto de Lafaille

×

Figure 6

Options: View larger image (or click on image) Download as PowerPoint
CD4+CD25+ T cells induced by oral tolerance are anergic and suppressive ...
CD4+CD25+ T cells induced by oral tolerance are anergic and suppressive in vitro. T/B monoclonal mice were administered OVA in drinking water and immunized with OVA-HA as represented in Figure 1A. Ten days after immunization, spleen and mLN cells were collected and pooled for the sorting of CD4+CD25+ and CD4+CD25– populations. Purified CD4+CD25– and CD4+CD25+ cells from Tol T/B monoclonal mice (Tol) or from BALB/c mice were stimulated in vitro with anti-CD3 antibodies and APCs (2 × 104 CD4 cells + 4 × 104 APC cells/well). For coculture experiments, 2 × 104 CD4+CD25– BALB/c cells (responder cells) were stimulated with anti-CD3 antibodies and APCs in the presence of putative suppressor cells from Tol or BALB/c mice at responder/suppressor ratios of 1.0:1.0, 1.0:0.3, and 1.0:0.1. Proliferation was determined by 3H-thymidine (3H-TdR) incorporation. Results are expressed as mean ± SD of triplicate wells.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts